New Human Embryonic Stem Cell Therapy Helps Cure Radiation Burn Wounds

Human Embryonic Stem Cell (HESC) therapy has helped to heal a deep wound in a woman's abdomen, who was undergoing radiation therapy for cancer. 35-year old Neelam, a mother of two, kept ignoring the fat deposit in her abdomen, thinking it was a regular feature for every married woman. However, she had to visit a doctor after a lump surfaced on her abdomen as the fat deposit grew. Doctors performed a surgery in which the lump was removed. However, Neelam was told that the lump was cancerous and she would have to undergo complete cancer treatment as there were chances of recurrence. As radiation therapy started, Neelam developed a deep burn wound on her abdomen.

Such was the condition of the wound that doctors had to stop the therapy and Neelam was asked to undergo another treatment for healing the wound, which started oozing white discharge that had a foul smell. As there were not many experts to treat a wound created by radiation therapy, Neelam was advised about HESC therapy and that Dr. Geeta Shroff was an expert in this new field.

After consulting Dr. Shroff, Neelam started undergoing HESC therapy, and was completely cured in three weeks following which she could continue her cancer treatment. Explaining about HESC therapy, Dr. Shroff said, "The therapy involves injecting isolated human embryonic stem cells into patients to help their body heal on its own in a natural way. The stem cell on entering the body engrafts in the appropriate tissue and supplements replacement or repair of the missing function of the body. The therapy has no known side effects."

Dr. Shroff, who has spent several years researching the benefits of HESC, said, "The therapy can be used for curing several other health problems such as spinal disorders. I have treated over 1,300 patients so far with no side effects, and have over 15 research papers published in journals in different parts of the world."

Dr. Shroff has multiple patents in 65 countries, including the US, Singapore, Japan, Australia and New Zealand, regarding the technology and its therapeutic application.

Source-IANS